Boehringer Ingelheim has launched a smaller, 12ml bottle of Senvelgo (velagliflozin), its treatment for feline diabetes, in Great Britain, Northern Ireland and Ireland.

This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.

Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”

https://senvelgo.co.uk 

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.